YangJDLarsonJJWattKD, et al.Hepatocellular carcinoma is the most common indication for liver transplantation and placement on the waitlist in the United States. Clin Gastroenterol Hepatol. 2017;15(5):767–775.e3. doi:10.1016/j.cgh.2016.11.034
2.
ZimmermanMAGhobrialRMTongMJ, et al.Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators. Arch Surg. 2008;143(2):182–188; discussion 188. doi:10.1001/archsurg.2007.39
3.
Fernandez-SevillaEAllardMASeltenJ, et al.Recurrence of hepatocellular carcinoma after liver transplantation: Is there a place for resection?Liver Transpl. 2017;23(4):440–447. doi:10.1002/lt.24742
4.
FilgueiraNA.Hepatocellular carcinoma recurrence after liver transplantation: risk factors, screening and clinical presentation. World J Hepatol. 2019;11(3):261–272. doi:10.4254/wjh.v11.i3.261
5.
SapisochinGGoldaracenaNAsteteS, et al.Benefit of treating hepatocellular carcinoma recurrence after liver transplantation and analysis of prognostic factors for survival in a large Euro-American series. Ann Surg Oncol. 2015;22(7):2286-2294. doi:10.1245/s10434-014-4273-6
